# AMIX — Autonomix Medical Inc · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** AMIX  
**Sources:** 30  
**Published:** 2026-08-05  
**Canonical:** https://app.k3vl4r.com/research/deep-research-amix-autonomix-medical-inc-catalysts-narrative-risks-1259

---

# Autonomix Medical, Inc. (AMIX) — Research Overview as of August 5, 2026

## Company Overview

Autonomix Medical is a medical device company focused on advancing precision nerve-targeted treatments, specifically a transvascular nerve ablation technology for treating severe pain associated with pancreatic cancer [[2]](https://ir.autonomix.com/press-releases/)[[6]](https://www.stocktitan.net/news/AMIX/autonomix-medical-inc-reports-positive-subgroup-results-xxxqdlgr7eeh.html).

---

## Key Recent Catalysts (Last ~1–3 Months)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-amix-autonomix-medical-inc-catalysts-narrative-risks-1259 (free to sign up)._